GlassScriptPhysician profile
Joyce H Hendry
NPI 1285767566
$2,088.78
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $538 · 2022: $435 · 2023: $592 · 2024: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $426.72 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $260.79 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.47 | 2021-2024 | |
| Novo Nordisk INC | $132.15 | 2021-2024 | Rybelsus, Ozempic |
| Galderma Laboratories, L.P. | $129.61 | 2021-2024 | |
| Glaxosmithkline, LLC. | $114.56 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.90 | 2021-2024 | Jardiance |
| Antares Pharma, INC. | $99.75 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Abbott Laboratories | $88.64 | 2022-2023 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $71.42 | 2023-2024 | Trintellix |
| Tris Pharma INC | $66.56 | 2024 | Dyanavel Xr |
| Kowa Pharmaceuticals America, INC. | $51.03 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.08 | 2022-2024 | Xifaxan |
| Dexcom, INC. | $45.13 | 2021-2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $35.44 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $34.80 | 2021 | |
| Corium, LLC | $32.37 | 2023 | Azstarys |
| Exact Sciences Corporation | $29.84 | 2024 | Cologuard Collection Kit |
| Halozyme INC | $24.84 | 2023 | |
| Bausch Health US, LLC | $22.24 | 2021 | |
| Impel Pharmaceuticals INC. | $20.53 | 2022 | |
| Nestle Healthcare Nutrition INC. | $17.29 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.63 | 2024 | Ajovy |
| Neos Therapeutics, LP | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Hendry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.